Amgen Inc.
COMPOSITIONS AND METHODS FOR TREATING LIVER CANCER
Last updated:
Abstract:
Methods and compositions for treating primary hepatic cancers and/or secondary hepatic cancers using a combination of talimogene laherparepvec and pembrolizumab, a pembrolizumab variant or an antigen-binding fragment thereof are provided.
Status:
Application
Type:
Utility
Filling date:
26 Oct 2018
Issue date:
12 Nov 2020